Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ACTRN12626000074392) titled 'Exercise intervention for people with systemic sclerosis: A randomised waitlist controlled trial' on Jan. 20.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: The University of Sydney
Condition:
Scleroderma
Scleroderma
Inflammatory and Immune System - Connective tissue diseases
Skin - Other skin conditions
Musculoskeletal - Other muscular and skeletal disorders
Intervention:
Intervention group (structured exercise)
This will be a 12 week structured exercise ...